Vera Therapeutics is a clinical- and commercial-stage biopharmaceutical company based in Brisbane, California, developing treatments for serious immunological and inflammatory diseases of the kidney. Its lead program, atacicept (marketed as TRUTAKNA), is a dual BAFF/APRIL inhibitor for IgA nephropathy (IgAN). - View it on GitHub